Andrew Marshall

Dr. Marshall is co-inventor of Healionics’ novel STAR biomaterial, and has over 15 years of experience developing this technology and its applications for improving the performance of implantable medical devices. He has led Healionics’ effort to successfully secure more than $7M in competitive non-dilutive SBIR grant awards from NIH and DOD, including $6M to advance STARgraft technology for maintaining the patency of synthetic blood vessels. He holds 25 issued and pending patents.

Dr. Marshall also serves on the Scientific Advisory Board for iSTAR Medical, Healionics’ Belgium-based ophthalmic device spinout. He designed the bio integrating porous biomaterial used in iSTAR’s glaucoma drainage devices, including MINIject, a novel micro-invasive glaucoma surgery (MIGS) device with exceptional early clinical results.

Dr. Marshall has been recognized as one of 40 Under 40 influential leaders and innovators by Medical Devices & Diagnostics Industry magazine, and he was honored at the 2012 World Congress on Tissue Engineering & Regenerative Medicine as the recipient of the Innovation/Commercialization Award.

Dr. Marshall earned his Ph.D. in Chemical Engineering from the University of Washington and has a BSE in Biomechanical Engineering from Stanford University.